bachelor's at Ciências Biológicas from Universidade Federal de Minas Gerais (1989), master's at Biochemistry from Fundação Oswaldo Cruz (1994) and doctorate at Biochemistry from Universidade Federal de Minas Gerais (1997). He is currently associate researcher at Universidade de São Paulo. Has experience in Biochemistry, focusing on Molecular Biology, acting on the following subjects: genome project, cancer, ests, pcr and orestes. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Intestinal bacteria can be used to predict occurrence of colorectal cancer |
| Intestinal bacteria can be used to predict occurrence of colorectal cancer |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Immune based therapeutics such as checkpoint inhibitors have proven to work across several cancer types and the potential impact novel immuno-oncology targets can have on inducing anti-cancer responses, either as standalone, or as combination/adjuvant therapies is great. Thus, our central overriding scientific focus is to discover and validate immunoregulatory targets with the potential t…
We do not know which variants of SARS-CoV-2 occur today in Brazil, an even worse situation in the different regions of the country. The little that is known is due to the study of patients with classic or suspected symptoms for COVID-19, whose material follows to determine the viral variant after diagnosis, which in the best scenario is determined several days after the onset of symptoms.…
Colorectal cancer (CRC) is a very importante malignancy, with an global anual rate of about 1.3 million new cases and 5-year survival rate of 50%. The vast majority jof the pacients (85%) can be offered surgery with curative intente, but a consederable part of them will recur with distant metástases. About two thirds of all CRC arise in the colon and after surgery chemotherapy is consider…
(Only some records are available in English at this moment)
Gastric cancer is a multifactorial disease with high incidence and mortality rates in Brazil and some areas of the world. Despite advances in diagnosis and treatment the overall survival rates are still low. Among the established risk factors for the development of the disease, such as diet and infection by H. pylori, it is notable that the imbalance of the gastric microbiota participates…
Despite the relative low incidence, when compared to other lung tumors, Small cell lung carcinoma (SCLC) is the most aggressive subtype, with high capacity of growth and dissemination. About 30% of patients diagnosed with SCLC do not respond to first line chemotherapy and relapse within 6 months. Mechanisms of tumor escape are still unknown, however they can involve: i) rapid evolution an…
(Only some records are available in English at this moment)
Nodal metastasis is the main prognostic factor for oral cancer patients. However, current technologies do not allow a reliable diagnosis of the metastatic dissemination to lymph nodes. In this way, the discovery of molecular markers of nodal metastasis will be of great value to prognosis and treatment of oral cancer patients. Salivary analysis has been described as a good diagnostic tool …
| 1 / 1 | Ongoing research grants |
| 12 / 9 | Completed research grants |
| 16 / 11 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 30 / 22 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID